TrialThe Journal of urology2014

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

David M Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.